Tag: Adjuvant

BRUSSELS; KENILWORTH, N.J., Mar. 17, 2022 – MSD, a trade name of Merck & Co., Inc, Kenilworth, NJ, USA., the ...

Men with microscopic evidence of prostate cancer spreading to their pelvic lymph nodes (LNs) following the surgical resection of the ...

Lugano, Switzerland, 18 September 2021 – The first randomised phase III clinical trial in stage II melanoma has shown a 35% reduction in the risk of recurrence with adjuvant pembrolizumab compared with ...